Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.
about
PEGylation improves the pharmacokinetic properties and ability of interferon gamma to inhibit growth of a human tumor xenograft in athymic mice.Stability and biological activity evaluations of PEGylated human basic fibroblast growth factor.PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
P2860
Site-specific PEGylation enhances the pharmacokinetic properties and antitumor activity of interferon beta-1b.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Site-specific PEGylation enhan ...... ctivity of interferon beta-1b.
@en
Site-specific PEGylation enhan ...... ctivity of interferon beta-1b.
@nl
type
label
Site-specific PEGylation enhan ...... ctivity of interferon beta-1b.
@en
Site-specific PEGylation enhan ...... ctivity of interferon beta-1b.
@nl
prefLabel
Site-specific PEGylation enhan ...... ctivity of interferon beta-1b.
@en
Site-specific PEGylation enhan ...... ctivity of interferon beta-1b.
@nl
P2093
P2860
P356
P1476
Site-specific PEGylation enhan ...... activity of interferon beta-1b
@en
P2093
Daniel H Doherty
Elizabeth A Chlipala
George N Cox
Jacquelyn D Brown
Stephen P Eisenberg
P2860
P304
P356
10.1089/JIR.2012.0148
P577
2013-08-20T00:00:00Z